Version May 2024
| Maternal |
| Medical or obstetric conditions associated with uteroplacental insufficiency (eg, preeclampsia, chronic hypertension, collagen vascular disease, nephropathy, thrombophilia) |
| Medications (eg, angiotensin converting enzyme inhibitors, prostaglandin synthetase inhibitors [eg, NSAIDs], trastuzumab) |
| Diabetes insipidus (rare cases have presented with oligohydramnios that improve upon maternal treatment with desmopressin) |
| Placental |
| Abruption |
| Twin to twin transfusion (ie, twin polyhydramnios-oligohydramnios sequence) |
| Placental thrombosis or infarction |
| Fetal |
| Chromosomal abnormalities |
| Congenital abnormalities, especially those associated with impaired urine production or excretion |
| Growth restriction |
| Demise |
| Postterm pregnancy |
| Ruptured fetal membranes |
| Infection |
| Idiopathic |
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟
